Rare diseases
Investigational molecules
Locations
Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
ItalyStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
ItalyStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
ItalyStudy on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
ItalyStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
ItalyStudy of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy
ItalyStudy on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema
ItalyStudy on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
ItalyStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
ItalyStudy of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer
ItalyStudy comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
ItalyStudy on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
